CALC insider filings
CalciMedica, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-10-05. Screen CALC transaction legs live →
Insider transaction summary — last 90 days
2026-07-10 to 2026-10-08, from the filings listed below: 18 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| WILSON ROBERT N — Director | 2 | — | — | 4 |
| Zaytsev Evgeny — Director | 2 | — | — | 4 |
| Hebbar Sudarshan — Chief Medical Officer | 2 | — | — | 3 |
| Leheny A. Rachel — CHIEF EXECUTIVE OFFICER, Director | 2 | — | — | 3 |
| ALAFI CAPITAL CO LLC — 10% owner | 1 | — | — | 2 |
| Glicklich Alan — Director | 2 | — | — | 2 |
| Guerard Frederic — Director | 2 | — | — | 2 |
| Roberts Eric W — CHIEF BUSINESS OFFICER, Director | 1 | — | — | 2 |
| Shaw Allan — Director | 2 | — | — | 2 |
| Bardin Stephen — Chief Financial Officer | 1 | — | — | 1 |
+1 more insider in the window, not shown — every filing appears in the table below.
Recent insider filings — CalciMedica, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-05 | 4 | Glicklich Alan — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2026-10-05 | 4 | Zaytsev Evgeny — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2026-10-05 | 4 | Guerard Frederic — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2026-10-05 | 4 | WILSON ROBERT N — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2026-10-05 | 4 | Shaw Allan — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2026-09-28 | 4 | Stauderman Kenneth A. — Chief Scientific Officer | Grant/award (A): 180,000 (derivative) @ $0 | EDGAR |
| 2026-09-28 | 4 | Hebbar Sudarshan — Chief Medical Officer | Grant/award (A): 180,000 (derivative) @ $0 | EDGAR |
| 2026-09-28 | 4 | Bardin Stephen — Chief Financial Officer | Grant/award (A): 190,000 (derivative) @ $0 | EDGAR |
| 2026-09-28 | 4 | Leheny A. Rachel — CHIEF EXECUTIVE OFFICER, Director | Grant/award (A): 360,000 (derivative) @ $0 | EDGAR |
| 2026-08-24 | 4 | ALAFI CAPITAL CO LLC — 10% owner | Grant/award (A): 3,529,192 (derivative) @ $0 · Grant/award (A): 3,529,192 (derivative) @ $0 | EDGAR |
| 2026-08-21 | 4 | Glicklich Alan — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-08-21 | 4 | Shaw Allan — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-08-21 | 4 | Zaytsev Evgeny — Director | Grant/award (A): 1,450,267 (derivative) @ $0 · Grant/award (A): 1,450,267 (derivative) @ $0 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-08-21 | 4 | Guerard Frederic — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-08-21 | 4 | WILSON ROBERT N — Director | Grant/award (A): 1,182,621 (derivative) @ $0 · Grant/award (A): 1,182,621 (derivative) @ $0 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-08-21 | 4 | Hebbar Sudarshan — Chief Medical Officer | Grant/award (A): 124,486 (derivative) @ $0 · Grant/award (A): 124,486 (derivative) @ $0 | EDGAR |
| 2026-08-21 | 4 | Leheny A. Rachel — CHIEF EXECUTIVE OFFICER, Director | Grant/award (A): 186,729 (derivative) @ $0 · Grant/award (A): 186,729 (derivative) @ $0 | EDGAR |
| 2026-08-21 | 4 | Roberts Eric W — CHIEF BUSINESS OFFICER, Director | Grant/award (A): 186,729 (derivative) @ $0 · Grant/award (A): 186,729 (derivative) @ $0 | EDGAR |
| 2026-07-07 | 4 | Zaytsev Evgeny — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2026-06-29 | 4 | Hebbar Sudarshan — Chief Medical Officer | Grant/award (A): 124,486 @ $0.80 | EDGAR |
| 2026-06-29 | 4 | Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% owner | Grant/award (A): 186,729 @ $0.80 | EDGAR |
| 2026-06-29 | 4 | Leheny A. Rachel — CHIEF EXECUTIVE OFFICER, Director, 10% owner | Grant/award (A): 186,729 @ $0.80 | EDGAR |
| 2026-06-29 | 4 | Middleton Fred A — Director, 10% owner | Purchase (P): 248,972 @ $0.80 | EDGAR |
| 2026-06-29 | 4 | WILSON ROBERT N — Director | Grant/award (A): 1,182,621 @ $0.80 | EDGAR |
| 2026-04-07 | 4 | Stauderman Kenneth A. — Chief Scientific Officer | Grant/award (A): 65,124 (derivative) @ $0 | EDGAR |
| 2026-04-07 | 4 | Hebbar Sudarshan — Chief Medical Officer | Grant/award (A): 91,173 (derivative) @ $0 | EDGAR |
| 2026-04-07 | 4 | Dunn Michael J. — President and COO | Grant/award (A): 65,124 (derivative) @ $0 | EDGAR |
| 2026-04-07 | 4 | Bardin Stephen — Chief Financial Officer | Grant/award (A): 67,728 (derivative) @ $0 | EDGAR |
| 2026-04-07 | 4 | Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% owner | Grant/award (A): 83,358 (derivative) @ $0 | EDGAR |
| 2026-04-07 | 4 | Leheny A. Rachel — CHIEF EXECUTIVE OFFICER, Director, 10% owner | Grant/award (A): 148,482 (derivative) @ $0 | EDGAR |
| 2025-10-14 | 4 | Glicklich Alan — Director | Grant/award (A): 937 (derivative) @ $0 | EDGAR |
| 2025-09-22 | 4 | Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% owner | Purchase (P): 2,500 @ $3.07 | EDGAR |
| 2025-09-17 | 4 | Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% owner | Purchase (P): 3,400 @ $2.68 | EDGAR |
| 2025-09-15 | 4 | Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% owner | Purchase (P): 5,000 @ $3.12 | EDGAR |
| 2025-09-11 | 4 | Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% owner | Purchase (P): 2,343 @ $3.15 | EDGAR |
| 2025-09-02 | 4 | Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% owner | Purchase (P): 9,200 @ $2.86 · Purchase (P): 800 @ $2.74 | EDGAR |
| 2025-08-25 | 4 | Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% owner | Purchase (P): 3,508 @ $2.79 | EDGAR |
| 2025-08-21 | 4 | Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% owner | Purchase (P): 1,000 @ $2.79 · Purchase (P): 2,000 @ $2.72 · Option exercise (M): 15,000 @ $1.53 · Option exercise (M): 15,000 (derivative) @ $1.53 | EDGAR |
| 2025-08-21 | 4 | Hebbar Sudarshan — Chief Medical Officer | Purchase (P): 9,563 @ $2.82 | EDGAR |
| 2025-08-19 | 4 | Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% owner | Purchase (P): 5,076 @ $2.90 | EDGAR |
| 2025-08-18 | 4 | Hebbar Sudarshan — Chief Medical Officer | Purchase (P): 1,584 @ $2.58 · Purchase (P): 4,392 @ $2.79 | EDGAR |
| 2025-07-29 | 4 | Stauderman Kenneth A. — Chief Scientific Officer | Sale (S): 1,000 @ $3.65 · Purchase (P): 1,000 @ $3.96 | EDGAR |
| 2025-07-23 | 4 | Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% owner | Purchase (P): 1,500 @ $3.77 | EDGAR |
| 2025-07-22 | 4 | Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% owner | Purchase (P): 1,500 @ $3.37 | EDGAR |
| 2025-07-21 | 4 | Leheny A. Rachel — CHIEF EXECUTIVE OFFICER, Director, 10% owner | Purchase (P): 1,000 @ $3.40 | EDGAR |
| 2025-07-18 | 4 | Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% owner | Purchase (P): 2,000 @ $2.88 | EDGAR |
| 2025-07-18 | 4 | WILSON ROBERT N — Director | Purchase (P): 4,500 @ $2.87 | EDGAR |
| 2025-07-16 | 4 | Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% owner | Purchase (P): 6,500 @ $2.43 | EDGAR |
| 2025-07-15 | 4 | Leheny A. Rachel — CHIEF EXECUTIVE OFFICER, Director, 10% owner | Purchase (P): 2,500 @ $2.47 | EDGAR |
| 2025-07-10 | 4 | Roberts Eric W — CHIEF BUSINESS OFFICER, Director, 10% owner | Purchase (P): 5,000 @ $1.60 | EDGAR |
Recent 8-K events — CalciMedica, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-30 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-16 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-09-02 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-08-27 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-20 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-07 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-06-24 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-24 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CALC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →